Zimmer Biomet legal chief sells $295K stock

Zimmer Biomet’s chief legal and corporate affairs officer sold 3,000 ZBH shares and now directly holds 65,231 shares.

Available on EDGAR 09/09/2026 - 04:13 PM EDT Accepted by SEC EDGAR 09/09/2026 - 04:12 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ZIMMER BIOMET HOLDINGS, INC. (ZBH) executive Chad F. Phipps, Senior Vice President, Chief Legal & Corporate Affairs Officer and Secretary, reported selling 3,000 shares of common stock on September 4, 2026 in an open-market or private transaction at $98.35 per share. After this sale, he directly holds 65,231 shares, which include 471 shares acquired under the Employee Stock Purchase Plan and through dividend reinvestment through July 31, 2026. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Net Seller: 3,000 shares

Net Sell 1 txn

Insider Phipps Chad F

Role See remarks below.

Sold 3,000 shs ($295K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	3,000	$98.35	$295K

Holdings After Transaction: Common Stock — 65,231 shares (Direct)

Footnotes (1)

1. F1. Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through July 31, 2026.

Key Figures

Shares sold: 3,000 shares Sale price per share: $98.35 per share Transaction value: $295,050 +2 more

5 metrics

Shares sold 3,000 shares Common stock sale reported for September 4, 2026

Sale price per share $98.35 per share Price for the 3,000 shares of common stock sold on September 4, 2026

Transaction value $295,050 Approximate aggregate value of 3,000 shares sold at $98.35 per share

Shares held after transaction 65,231 shares Directly held Zimmer Biomet common shares following the reported sale

Shares from Employee Stock Purchase Plan and dividend reinvestment 471 shares Included within the post-transaction direct holdings through July 31, 2026

Key Terms

Employee Stock Purchase Plan, dividend reinvestment, open market or private transaction

3 terms

Employee Stock Purchase Plan financial

"Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

dividend reinvestment financial

"Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ZBH shares did Chad F. Phipps sell in this Form 4 filing?

He reported selling 3,000 shares of Zimmer Biomet common stock on September 4, 2026 in an open-market or private transaction at $98.35 per share.

What is Chad F. Phipps’s remaining ZBH shareholding after this transaction?

Following the reported sale, Chad F. Phipps directly holds 65,231 shares of Zimmer Biomet common stock, according to the Form 4 disclosure.

What was the approximate dollar value of the ZBH shares sold by Chad F. Phipps?

The sale of 3,000 shares at $98.35 per share represents an aggregate value of approximately $295,050, based on the reported transaction price and share amount.

Were any of Chad F. Phipps’s remaining ZBH shares acquired through an employee plan?

Yes. The Form 4 footnote states that his reported holdings include 471 shares acquired under the Employee Stock Purchase Plan and through dividend reinvestment through July 31, 2026.

Was the ZBH stock sale by Chad F. Phipps made under a Rule 10b5-1 trading plan?

No. The filing indicates that no Rule 10b5-1 trading plan is reported for this transaction.

What is Chad F. Phipps’s role at Zimmer Biomet (ZBH)?

Chad F. Phipps is identified as Zimmer Biomet’s Senior Vice President, Chief Legal & Corporate Affairs Officer and Secretary in the Form 4 remarks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Phipps Chad F

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW INDIANA 46580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks below.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2026		S		3,000	D	$98.35	65,231(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through July 31, 2026.

Remarks:

Senior Vice President, Chief Legal & Corporate Affairs Officer and Secretary

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Chad F. Phipps (power of attorney previously filed)	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)